nodes	percent_of_prediction	percent_of_DWPC	metapath
Progesterone—CYP2A6—lung cancer	0.143	0.482	CbGaD
Progesterone—CYP1A1—lung cancer	0.1	0.338	CbGaD
Progesterone—ABCB1—lung cancer	0.0532	0.18	CbGaD
Progesterone—CYP1B1—Erlotinib—lung cancer	0.0198	0.0433	CbGbCtD
Progesterone—SLC22A3—Irinotecan—lung cancer	0.0194	0.0425	CbGbCtD
Progesterone—ABCB11—Paclitaxel—lung cancer	0.0181	0.0396	CbGbCtD
Progesterone—CYP1B1—Paclitaxel—lung cancer	0.0181	0.0396	CbGbCtD
Progesterone—ABCB11—Vinblastine—lung cancer	0.0159	0.0348	CbGbCtD
Progesterone—CYP1A1—Gefitinib—lung cancer	0.0147	0.0321	CbGbCtD
Progesterone—CYP1B1—Docetaxel—lung cancer	0.0131	0.0287	CbGbCtD
Progesterone—ABCC1—Paclitaxel—lung cancer	0.0129	0.0282	CbGbCtD
Progesterone—ABCC1—Irinotecan—lung cancer	0.0127	0.0278	CbGbCtD
Progesterone—ABCC1—Vinblastine—lung cancer	0.0113	0.0247	CbGbCtD
Progesterone—SLC22A2—Vinblastine—lung cancer	0.0102	0.0224	CbGbCtD
Progesterone—ABCC1—Etoposide—lung cancer	0.0102	0.0223	CbGbCtD
Progesterone—CYP1B1—Doxorubicin—lung cancer	0.00976	0.0214	CbGbCtD
Progesterone—ABCB11—Doxorubicin—lung cancer	0.00976	0.0214	CbGbCtD
Progesterone—SLC22A2—Cisplatin—lung cancer	0.00938	0.0205	CbGbCtD
Progesterone—ABCC1—Docetaxel—lung cancer	0.0093	0.0204	CbGbCtD
Progesterone—CYP3A5—Gefitinib—lung cancer	0.00882	0.0193	CbGbCtD
Progesterone—CYP1A1—Erlotinib—lung cancer	0.00868	0.019	CbGbCtD
Progesterone—CYP3A5—Teniposide—lung cancer	0.00855	0.0187	CbGbCtD
Progesterone—CYP2C19—Gefitinib—lung cancer	0.00711	0.0156	CbGbCtD
Progesterone—ABCC1—Doxorubicin—lung cancer	0.00694	0.0152	CbGbCtD
Progesterone—CYP2C19—Teniposide—lung cancer	0.0069	0.0151	CbGbCtD
Progesterone—ABCC1—Methotrexate—lung cancer	0.00672	0.0147	CbGbCtD
Progesterone—CYP3A7—Paclitaxel—lung cancer	0.00636	0.0139	CbGbCtD
Progesterone—CYP3A7-CYP3A51P—Paclitaxel—lung cancer	0.00636	0.0139	CbGbCtD
Progesterone—CYP3A7—Irinotecan—lung cancer	0.00627	0.0137	CbGbCtD
Progesterone—CYP3A7-CYP3A51P—Irinotecan—lung cancer	0.00627	0.0137	CbGbCtD
Progesterone—ABCB1—Topotecan—lung cancer	0.00627	0.0137	CbGbCtD
Progesterone—CYP2C9—Gefitinib—lung cancer	0.00591	0.0129	CbGbCtD
Progesterone—ABCB1—Gefitinib—lung cancer	0.00574	0.0126	CbGbCtD
Progesterone—CYP2C9—Teniposide—lung cancer	0.00573	0.0125	CbGbCtD
Progesterone—CYP2D6—Gefitinib—lung cancer	0.00541	0.0118	CbGbCtD
Progesterone—CYP3A5—Crizotinib—lung cancer	0.0054	0.0118	CbGbCtD
Progesterone—CYP3A5—Erlotinib—lung cancer	0.00521	0.0114	CbGbCtD
Progesterone—CYP2C8—Erlotinib—lung cancer	0.00501	0.011	CbGbCtD
Progesterone—CYP3A5—Paclitaxel—lung cancer	0.00477	0.0104	CbGbCtD
Progesterone—CYP3A5—Irinotecan—lung cancer	0.00471	0.0103	CbGbCtD
Progesterone—CYP3A7-CYP3A51P—Docetaxel—lung cancer	0.0046	0.0101	CbGbCtD
Progesterone—CYP3A7—Docetaxel—lung cancer	0.0046	0.0101	CbGbCtD
Progesterone—CYP2C8—Paclitaxel—lung cancer	0.00459	0.01	CbGbCtD
Progesterone—ABCB1—Vinorelbine—lung cancer	0.00442	0.00967	CbGbCtD
Progesterone—CYP2D6—Vinorelbine—lung cancer	0.00416	0.00911	CbGbCtD
Progesterone—CYP1A2—Erlotinib—lung cancer	0.00388	0.00849	CbGbCtD
Progesterone—CYP3A5—Etoposide—lung cancer	0.00377	0.00825	CbGbCtD
Progesterone—CYP3A4—Topotecan—lung cancer	0.00376	0.00822	CbGbCtD
Progesterone—CYP2C8—Etoposide—lung cancer	0.00362	0.00793	CbGbCtD
Progesterone—ABCB1—Crizotinib—lung cancer	0.00352	0.0077	CbGbCtD
Progesterone—CYP3A5—Docetaxel—lung cancer	0.00345	0.00755	CbGbCtD
Progesterone—CYP3A4—Gefitinib—lung cancer	0.00344	0.00752	CbGbCtD
Progesterone—ABCB1—Gemcitabine—lung cancer	0.00344	0.00752	CbGbCtD
Progesterone—ABCB1—Erlotinib—lung cancer	0.00339	0.00742	CbGbCtD
Progesterone—CYP3A4—Teniposide—lung cancer	0.00333	0.00729	CbGbCtD
Progesterone—CYP2C9—Paclitaxel—lung cancer	0.0032	0.007	CbGbCtD
Progesterone—CYP2D6—Erlotinib—lung cancer	0.0032	0.00699	CbGbCtD
Progesterone—ABCB1—Paclitaxel—lung cancer	0.00311	0.0068	CbGbCtD
Progesterone—ABCB1—Irinotecan—lung cancer	0.00306	0.0067	CbGbCtD
Progesterone—CYP1A2—Etoposide—lung cancer	0.00281	0.00614	CbGbCtD
Progesterone—ABCB1—Vinblastine—lung cancer	0.00272	0.00596	CbGbCtD
Progesterone—CYP3A4—Vinorelbine—lung cancer	0.00265	0.00579	CbGbCtD
Progesterone—CYP2C9—Cisplatin—lung cancer	0.00257	0.00563	CbGbCtD
Progesterone—CYP2D6—Vinblastine—lung cancer	0.00257	0.00562	CbGbCtD
Progesterone—ABCB1—Cisplatin—lung cancer	0.0025	0.00546	CbGbCtD
Progesterone—ABCB1—Etoposide—lung cancer	0.00245	0.00537	CbGbCtD
Progesterone—ABCB1—Docetaxel—lung cancer	0.00225	0.00491	CbGbCtD
Progesterone—CYP3A4—Crizotinib—lung cancer	0.00211	0.00461	CbGbCtD
Progesterone—CYP3A4—Erlotinib—lung cancer	0.00203	0.00445	CbGbCtD
Progesterone—CYP3A4—Paclitaxel—lung cancer	0.00186	0.00407	CbGbCtD
Progesterone—CYP3A4—Irinotecan—lung cancer	0.00184	0.00402	CbGbCtD
Progesterone—ABCB1—Doxorubicin—lung cancer	0.00167	0.00366	CbGbCtD
Progesterone—CYP3A4—Vinblastine—lung cancer	0.00163	0.00357	CbGbCtD
Progesterone—ABCB1—Methotrexate—lung cancer	0.00162	0.00355	CbGbCtD
Progesterone—CYP2D6—Doxorubicin—lung cancer	0.00158	0.00345	CbGbCtD
Progesterone—CYP3A4—Etoposide—lung cancer	0.00147	0.00322	CbGbCtD
Progesterone—CYP3A4—Docetaxel—lung cancer	0.00135	0.00294	CbGbCtD
Progesterone—CYP3A4—Doxorubicin—lung cancer	0.001	0.00219	CbGbCtD
Progesterone—PGR—mammary gland—lung cancer	0.000674	0.0405	CbGeAlD
Progesterone—SIGMAR1—mammary gland—lung cancer	0.000596	0.0358	CbGeAlD
Progesterone—CYP1B1—mammary gland—lung cancer	0.000567	0.034	CbGeAlD
Progesterone—ESR1—mammary gland—lung cancer	0.000527	0.0317	CbGeAlD
Progesterone—PGR—respiratory system—lung cancer	0.000449	0.027	CbGeAlD
Progesterone—CYP2C8—mammary gland—lung cancer	0.000434	0.0261	CbGeAlD
Progesterone—NR3C2—bronchus—lung cancer	0.000398	0.0239	CbGeAlD
Progesterone—CYP2C9—mammary gland—lung cancer	0.000386	0.0232	CbGeAlD
Progesterone—CYP1B1—respiratory system—lung cancer	0.000378	0.0227	CbGeAlD
Progesterone—PGR—epithelium—lung cancer	0.000375	0.0225	CbGeAlD
Progesterone—NR3C2—trachea—lung cancer	0.000357	0.0214	CbGeAlD
Progesterone—Hydrocortisone—ANXA1—lung cancer	0.000356	0.218	CrCbGaD
Progesterone—ESR1—respiratory system—lung cancer	0.000351	0.0211	CbGeAlD
Progesterone—NR3C2—cardiac atrium—lung cancer	0.000335	0.0201	CbGeAlD
Progesterone—SIGMAR1—bronchus—lung cancer	0.000327	0.0196	CbGeAlD
Progesterone—Testosterone Propionate—UGT1A1—lung cancer	0.000308	0.189	CrCbGaD
Progesterone—AR—epithelium—lung cancer	0.000299	0.018	CbGeAlD
Progesterone—AR—bronchus—lung cancer	0.000294	0.0177	CbGeAlD
Progesterone—SIGMAR1—trachea—lung cancer	0.000294	0.0176	CbGeAlD
Progesterone—ESR1—epithelium—lung cancer	0.000293	0.0176	CbGeAlD
Progesterone—SHBG—bone marrow—lung cancer	0.000292	0.0175	CbGeAlD
Progesterone—ABCC1—bronchus—lung cancer	0.00028	0.0168	CbGeAlD
Progesterone—SIGMAR1—cardiac atrium—lung cancer	0.000276	0.0166	CbGeAlD
Progesterone—CYP2A6—lung—lung cancer	0.000274	0.0164	CbGeAlD
Progesterone—CYP1A2—respiratory system—lung cancer	0.000271	0.0163	CbGeAlD
Progesterone—CYP1A1—respiratory system—lung cancer	0.000267	0.016	CbGeAlD
Progesterone—CYP3A5—respiratory system—lung cancer	0.000261	0.0157	CbGeAlD
Progesterone—NR3C1—respiratory system—lung cancer	0.000259	0.0156	CbGeAlD
Progesterone—NR3C2—lung—lung cancer	0.000256	0.0154	CbGeAlD
Progesterone—ABCC1—trachea—lung cancer	0.000251	0.0151	CbGeAlD
Progesterone—AR—cardiac atrium—lung cancer	0.000248	0.0149	CbGeAlD
Progesterone—CYP17A1—lymph node—lung cancer	0.000243	0.0146	CbGeAlD
Progesterone—PGR—lung—lung cancer	0.000238	0.0143	CbGeAlD
Progesterone—ABCC1—cardiac atrium—lung cancer	0.000236	0.0142	CbGeAlD
Progesterone—SIGMAR1—bone marrow—lung cancer	0.000233	0.014	CbGeAlD
Progesterone—CYP1A1—epithelium—lung cancer	0.000223	0.0134	CbGeAlD
Progesterone—CYP1A1—bronchus—lung cancer	0.00022	0.0132	CbGeAlD
Progesterone—SLC22A3—lung—lung cancer	0.000218	0.0131	CbGeAlD
Progesterone—NR3C1—epithelium—lung cancer	0.000217	0.013	CbGeAlD
Progesterone—NR3C1—bronchus—lung cancer	0.000213	0.0128	CbGeAlD
Progesterone—SIGMAR1—lung—lung cancer	0.000211	0.0127	CbGeAlD
Progesterone—CYP1B1—lung—lung cancer	0.000201	0.012	CbGeAlD
Progesterone—CYP1A1—trachea—lung cancer	0.000197	0.0119	CbGeAlD
Progesterone—NR3C1—trachea—lung cancer	0.000191	0.0115	CbGeAlD
Progesterone—AR—lung—lung cancer	0.00019	0.0114	CbGeAlD
Progesterone—ESR1—lung—lung cancer	0.000186	0.0112	CbGeAlD
Progesterone—CYP1A1—cardiac atrium—lung cancer	0.000185	0.0111	CbGeAlD
Progesterone—ABCC1—lung—lung cancer	0.00018	0.0108	CbGeAlD
Progesterone—NR3C1—cardiac atrium—lung cancer	0.00018	0.0108	CbGeAlD
Progesterone—NR3C2—lymph node—lung cancer	0.000175	0.0105	CbGeAlD
Progesterone—PGR—lymph node—lung cancer	0.000163	0.00979	CbGeAlD
Progesterone—NR3C1—bone marrow—lung cancer	0.000152	0.00912	CbGeAlD
Progesterone—SLC22A3—lymph node—lung cancer	0.000149	0.00896	CbGeAlD
Progesterone—SIGMAR1—lymph node—lung cancer	0.000144	0.00867	CbGeAlD
Progesterone—CYP1A2—lung—lung cancer	0.000144	0.00863	CbGeAlD
Progesterone—Prednisolone—CYP2A6—lung cancer	0.000143	0.0876	CrCbGaD
Progesterone—CYP1A1—lung—lung cancer	0.000142	0.00852	CbGeAlD
Progesterone—ABCB1—respiratory system—lung cancer	0.000139	0.00833	CbGeAlD
Progesterone—CYP3A5—lung—lung cancer	0.000139	0.00833	CbGeAlD
Progesterone—NR3C1—lung—lung cancer	0.000138	0.00826	CbGeAlD
Progesterone—CYP1B1—lymph node—lung cancer	0.000137	0.00824	CbGeAlD
Progesterone—AR—lymph node—lung cancer	0.00013	0.0078	CbGeAlD
Progesterone—ESR1—lymph node—lung cancer	0.000128	0.00766	CbGeAlD
Progesterone—ABCC1—lymph node—lung cancer	0.000123	0.00741	CbGeAlD
Progesterone—ABCB1—epithelium—lung cancer	0.000116	0.00696	CbGeAlD
Progesterone—ABCB1—trachea—lung cancer	0.000102	0.00616	CbGeAlD
Progesterone—Drospirenone—PTGS2—lung cancer	0.000101	0.062	CrCbGaD
Progesterone—Megestrol acetate—ABCB1—lung cancer	9.84e-05	0.0604	CrCbGaD
Progesterone—Hydrocortisone—ABCG2—lung cancer	9.77e-05	0.0599	CrCbGaD
Progesterone—CYP1A1—lymph node—lung cancer	9.7e-05	0.00582	CbGeAlD
Progesterone—NR3C1—lymph node—lung cancer	9.41e-05	0.00565	CbGeAlD
Progesterone—ABCB1—bone marrow—lung cancer	8.13e-05	0.00488	CbGeAlD
Progesterone—Testosterone—ABCG2—lung cancer	7.52e-05	0.0461	CrCbGaD
Progesterone—ABCB1—lung—lung cancer	7.36e-05	0.00442	CbGeAlD
Progesterone—Spironolactone—ABCB1—lung cancer	6.12e-05	0.0375	CrCbGaD
Progesterone—Norethindrone—ALB—lung cancer	5.95e-05	0.0365	CrCbGaD
Progesterone—Testosterone—CYP1A1—lung cancer	5.89e-05	0.0361	CrCbGaD
Progesterone—Norethindrone—ABCB1—lung cancer	5.68e-05	0.0349	CrCbGaD
Progesterone—Methyltestosterone—ALB—lung cancer	5.65e-05	0.0347	CrCbGaD
Progesterone—Prednisolone—ABCB1—lung cancer	5.31e-05	0.0326	CrCbGaD
Progesterone—ABCB1—lymph node—lung cancer	5.04e-05	0.00303	CbGeAlD
Progesterone—Hydrocortisone—ABCB1—lung cancer	4.06e-05	0.0249	CrCbGaD
Progesterone—Haemoglobin—Methotrexate—lung cancer	4e-05	0.00031	CcSEcCtD
Progesterone—Gastrointestinal disorder—Paclitaxel—lung cancer	4e-05	0.00031	CcSEcCtD
Progesterone—Fatigue—Paclitaxel—lung cancer	3.99e-05	0.000309	CcSEcCtD
Progesterone—Haemorrhage—Methotrexate—lung cancer	3.98e-05	0.000309	CcSEcCtD
Progesterone—Hepatitis—Methotrexate—lung cancer	3.98e-05	0.000309	CcSEcCtD
Progesterone—Pollakiuria—Doxorubicin—lung cancer	3.98e-05	0.000308	CcSEcCtD
Progesterone—Asthenia—Gemcitabine—lung cancer	3.97e-05	0.000307	CcSEcCtD
Progesterone—Pain—Paclitaxel—lung cancer	3.96e-05	0.000307	CcSEcCtD
Progesterone—Constipation—Paclitaxel—lung cancer	3.96e-05	0.000307	CcSEcCtD
Progesterone—Confusional state—Docetaxel—lung cancer	3.96e-05	0.000307	CcSEcCtD
Progesterone—Pharyngitis—Methotrexate—lung cancer	3.95e-05	0.000306	CcSEcCtD
Progesterone—Urinary tract disorder—Methotrexate—lung cancer	3.93e-05	0.000305	CcSEcCtD
Progesterone—Oedema—Docetaxel—lung cancer	3.93e-05	0.000304	CcSEcCtD
Progesterone—Anaphylactic shock—Docetaxel—lung cancer	3.93e-05	0.000304	CcSEcCtD
Progesterone—Weight increased—Doxorubicin—lung cancer	3.92e-05	0.000304	CcSEcCtD
Progesterone—Pruritus—Gemcitabine—lung cancer	3.91e-05	0.000303	CcSEcCtD
Progesterone—Urethral disorder—Methotrexate—lung cancer	3.9e-05	0.000302	CcSEcCtD
Progesterone—Infection—Docetaxel—lung cancer	3.9e-05	0.000302	CcSEcCtD
Progesterone—Weight decreased—Doxorubicin—lung cancer	3.9e-05	0.000302	CcSEcCtD
Progesterone—Feeling abnormal—Etoposide—lung cancer	3.89e-05	0.000302	CcSEcCtD
Progesterone—Hyperglycaemia—Doxorubicin—lung cancer	3.89e-05	0.000301	CcSEcCtD
Progesterone—Diarrhoea—Irinotecan—lung cancer	3.89e-05	0.000301	CcSEcCtD
Progesterone—Pneumonia—Doxorubicin—lung cancer	3.86e-05	0.000299	CcSEcCtD
Progesterone—Gastrointestinal pain—Etoposide—lung cancer	3.86e-05	0.000299	CcSEcCtD
Progesterone—Shock—Docetaxel—lung cancer	3.86e-05	0.000299	CcSEcCtD
Progesterone—Nervous system disorder—Docetaxel—lung cancer	3.85e-05	0.000298	CcSEcCtD
Progesterone—Infestation NOS—Doxorubicin—lung cancer	3.84e-05	0.000298	CcSEcCtD
Progesterone—Drowsiness—Doxorubicin—lung cancer	3.84e-05	0.000298	CcSEcCtD
Progesterone—Infestation—Doxorubicin—lung cancer	3.84e-05	0.000298	CcSEcCtD
Progesterone—Visual impairment—Methotrexate—lung cancer	3.84e-05	0.000297	CcSEcCtD
Progesterone—Tachycardia—Docetaxel—lung cancer	3.83e-05	0.000297	CcSEcCtD
Progesterone—Feeling abnormal—Paclitaxel—lung cancer	3.82e-05	0.000296	CcSEcCtD
Progesterone—Skin disorder—Docetaxel—lung cancer	3.81e-05	0.000295	CcSEcCtD
Progesterone—Hypersensitivity—Cisplatin—lung cancer	3.8e-05	0.000294	CcSEcCtD
Progesterone—Gastrointestinal pain—Paclitaxel—lung cancer	3.79e-05	0.000293	CcSEcCtD
Progesterone—Diarrhoea—Gemcitabine—lung cancer	3.79e-05	0.000293	CcSEcCtD
Progesterone—Erythema multiforme—Methotrexate—lung cancer	3.77e-05	0.000292	CcSEcCtD
Progesterone—Neuropathy peripheral—Doxorubicin—lung cancer	3.77e-05	0.000292	CcSEcCtD
Progesterone—Dizziness—Irinotecan—lung cancer	3.76e-05	0.000291	CcSEcCtD
Progesterone—Urticaria—Etoposide—lung cancer	3.75e-05	0.000291	CcSEcCtD
Progesterone—Jaundice—Doxorubicin—lung cancer	3.75e-05	0.00029	CcSEcCtD
Progesterone—Anorexia—Docetaxel—lung cancer	3.74e-05	0.00029	CcSEcCtD
Progesterone—Body temperature increased—Etoposide—lung cancer	3.74e-05	0.000289	CcSEcCtD
Progesterone—Abdominal pain—Etoposide—lung cancer	3.74e-05	0.000289	CcSEcCtD
Progesterone—Conjunctivitis—Doxorubicin—lung cancer	3.73e-05	0.000289	CcSEcCtD
Progesterone—Urinary tract infection—Doxorubicin—lung cancer	3.73e-05	0.000289	CcSEcCtD
Progesterone—Eye disorder—Methotrexate—lung cancer	3.72e-05	0.000288	CcSEcCtD
Progesterone—Tinnitus—Methotrexate—lung cancer	3.71e-05	0.000288	CcSEcCtD
Progesterone—Asthenia—Cisplatin—lung cancer	3.7e-05	0.000287	CcSEcCtD
Progesterone—Cardiac disorder—Methotrexate—lung cancer	3.7e-05	0.000286	CcSEcCtD
Progesterone—Urticaria—Paclitaxel—lung cancer	3.68e-05	0.000285	CcSEcCtD
Progesterone—Hypotension—Docetaxel—lung cancer	3.67e-05	0.000284	CcSEcCtD
Progesterone—Body temperature increased—Paclitaxel—lung cancer	3.66e-05	0.000284	CcSEcCtD
Progesterone—Abdominal pain—Paclitaxel—lung cancer	3.66e-05	0.000284	CcSEcCtD
Progesterone—Hepatobiliary disease—Doxorubicin—lung cancer	3.63e-05	0.000281	CcSEcCtD
Progesterone—Angiopathy—Methotrexate—lung cancer	3.61e-05	0.00028	CcSEcCtD
Progesterone—Vomiting—Irinotecan—lung cancer	3.61e-05	0.00028	CcSEcCtD
Progesterone—Sinusitis—Doxorubicin—lung cancer	3.6e-05	0.000279	CcSEcCtD
Progesterone—Immune system disorder—Methotrexate—lung cancer	3.6e-05	0.000279	CcSEcCtD
Progesterone—Mediastinal disorder—Methotrexate—lung cancer	3.59e-05	0.000278	CcSEcCtD
Progesterone—Rash—Irinotecan—lung cancer	3.58e-05	0.000277	CcSEcCtD
Progesterone—Dermatitis—Irinotecan—lung cancer	3.58e-05	0.000277	CcSEcCtD
Progesterone—Musculoskeletal discomfort—Docetaxel—lung cancer	3.58e-05	0.000277	CcSEcCtD
Progesterone—Headache—Irinotecan—lung cancer	3.56e-05	0.000276	CcSEcCtD
Progesterone—Insomnia—Docetaxel—lung cancer	3.55e-05	0.000275	CcSEcCtD
Progesterone—Diarrhoea—Cisplatin—lung cancer	3.53e-05	0.000273	CcSEcCtD
Progesterone—Paraesthesia—Docetaxel—lung cancer	3.53e-05	0.000273	CcSEcCtD
Progesterone—Alopecia—Methotrexate—lung cancer	3.52e-05	0.000273	CcSEcCtD
Progesterone—Vomiting—Gemcitabine—lung cancer	3.52e-05	0.000272	CcSEcCtD
Progesterone—Dyspnoea—Docetaxel—lung cancer	3.5e-05	0.000271	CcSEcCtD
Progesterone—Somnolence—Docetaxel—lung cancer	3.49e-05	0.00027	CcSEcCtD
Progesterone—Mental disorder—Methotrexate—lung cancer	3.49e-05	0.00027	CcSEcCtD
Progesterone—Rash—Gemcitabine—lung cancer	3.49e-05	0.00027	CcSEcCtD
Progesterone—Dermatitis—Gemcitabine—lung cancer	3.49e-05	0.00027	CcSEcCtD
Progesterone—Hypersensitivity—Etoposide—lung cancer	3.48e-05	0.00027	CcSEcCtD
Progesterone—Erythema—Methotrexate—lung cancer	3.47e-05	0.000269	CcSEcCtD
Progesterone—Malnutrition—Methotrexate—lung cancer	3.47e-05	0.000269	CcSEcCtD
Progesterone—Haemoglobin—Doxorubicin—lung cancer	3.47e-05	0.000269	CcSEcCtD
Progesterone—Headache—Gemcitabine—lung cancer	3.47e-05	0.000268	CcSEcCtD
Progesterone—Rhinitis—Doxorubicin—lung cancer	3.46e-05	0.000268	CcSEcCtD
Progesterone—Dyspepsia—Docetaxel—lung cancer	3.46e-05	0.000268	CcSEcCtD
Progesterone—Hepatitis—Doxorubicin—lung cancer	3.45e-05	0.000267	CcSEcCtD
Progesterone—Haemorrhage—Doxorubicin—lung cancer	3.45e-05	0.000267	CcSEcCtD
Progesterone—Pharyngitis—Doxorubicin—lung cancer	3.42e-05	0.000265	CcSEcCtD
Progesterone—Decreased appetite—Docetaxel—lung cancer	3.41e-05	0.000264	CcSEcCtD
Progesterone—Hypersensitivity—Paclitaxel—lung cancer	3.41e-05	0.000264	CcSEcCtD
Progesterone—Urinary tract disorder—Doxorubicin—lung cancer	3.41e-05	0.000264	CcSEcCtD
Progesterone—Oedema peripheral—Doxorubicin—lung cancer	3.4e-05	0.000263	CcSEcCtD
Progesterone—Gastrointestinal disorder—Docetaxel—lung cancer	3.39e-05	0.000263	CcSEcCtD
Progesterone—Asthenia—Etoposide—lung cancer	3.39e-05	0.000263	CcSEcCtD
Progesterone—Connective tissue disorder—Doxorubicin—lung cancer	3.39e-05	0.000263	CcSEcCtD
Progesterone—Fatigue—Docetaxel—lung cancer	3.39e-05	0.000262	CcSEcCtD
Progesterone—Urethral disorder—Doxorubicin—lung cancer	3.38e-05	0.000262	CcSEcCtD
Progesterone—Nausea—Irinotecan—lung cancer	3.37e-05	0.000261	CcSEcCtD
Progesterone—Pain—Docetaxel—lung cancer	3.36e-05	0.00026	CcSEcCtD
Progesterone—Constipation—Docetaxel—lung cancer	3.36e-05	0.00026	CcSEcCtD
Progesterone—Back pain—Methotrexate—lung cancer	3.35e-05	0.00026	CcSEcCtD
Progesterone—Pruritus—Etoposide—lung cancer	3.34e-05	0.000259	CcSEcCtD
Progesterone—Visual impairment—Doxorubicin—lung cancer	3.32e-05	0.000257	CcSEcCtD
Progesterone—Asthenia—Paclitaxel—lung cancer	3.32e-05	0.000257	CcSEcCtD
Progesterone—Nausea—Gemcitabine—lung cancer	3.29e-05	0.000255	CcSEcCtD
Progesterone—Testosterone—ALB—lung cancer	3.28e-05	0.0201	CrCbGaD
Progesterone—Vomiting—Cisplatin—lung cancer	3.28e-05	0.000254	CcSEcCtD
Progesterone—Pruritus—Paclitaxel—lung cancer	3.28e-05	0.000254	CcSEcCtD
Progesterone—Vision blurred—Methotrexate—lung cancer	3.27e-05	0.000253	CcSEcCtD
Progesterone—Erythema multiforme—Doxorubicin—lung cancer	3.26e-05	0.000253	CcSEcCtD
Progesterone—Rash—Cisplatin—lung cancer	3.25e-05	0.000252	CcSEcCtD
Progesterone—Dermatitis—Cisplatin—lung cancer	3.25e-05	0.000252	CcSEcCtD
Progesterone—Feeling abnormal—Docetaxel—lung cancer	3.24e-05	0.000251	CcSEcCtD
Progesterone—Diarrhoea—Etoposide—lung cancer	3.23e-05	0.00025	CcSEcCtD
Progesterone—Eye disorder—Doxorubicin—lung cancer	3.22e-05	0.00025	CcSEcCtD
Progesterone—Ill-defined disorder—Methotrexate—lung cancer	3.22e-05	0.000249	CcSEcCtD
Progesterone—Tinnitus—Doxorubicin—lung cancer	3.22e-05	0.000249	CcSEcCtD
Progesterone—Gastrointestinal pain—Docetaxel—lung cancer	3.21e-05	0.000249	CcSEcCtD
Progesterone—Anaemia—Methotrexate—lung cancer	3.21e-05	0.000248	CcSEcCtD
Progesterone—Cardiac disorder—Doxorubicin—lung cancer	3.2e-05	0.000248	CcSEcCtD
Progesterone—Diarrhoea—Paclitaxel—lung cancer	3.17e-05	0.000245	CcSEcCtD
Progesterone—Testosterone—ABCB1—lung cancer	3.13e-05	0.0192	CrCbGaD
Progesterone—Angiopathy—Doxorubicin—lung cancer	3.13e-05	0.000242	CcSEcCtD
Progesterone—Malaise—Methotrexate—lung cancer	3.13e-05	0.000242	CcSEcCtD
Progesterone—Dizziness—Etoposide—lung cancer	3.12e-05	0.000242	CcSEcCtD
Progesterone—Immune system disorder—Doxorubicin—lung cancer	3.12e-05	0.000241	CcSEcCtD
Progesterone—Vertigo—Methotrexate—lung cancer	3.12e-05	0.000241	CcSEcCtD
Progesterone—Mediastinal disorder—Doxorubicin—lung cancer	3.11e-05	0.000241	CcSEcCtD
Progesterone—Abdominal pain—Docetaxel—lung cancer	3.1e-05	0.00024	CcSEcCtD
Progesterone—Body temperature increased—Docetaxel—lung cancer	3.1e-05	0.00024	CcSEcCtD
Progesterone—Dizziness—Paclitaxel—lung cancer	3.06e-05	0.000237	CcSEcCtD
Progesterone—Nausea—Cisplatin—lung cancer	3.06e-05	0.000237	CcSEcCtD
Progesterone—Alopecia—Doxorubicin—lung cancer	3.05e-05	0.000236	CcSEcCtD
Progesterone—Cough—Methotrexate—lung cancer	3.03e-05	0.000234	CcSEcCtD
Progesterone—Mental disorder—Doxorubicin—lung cancer	3.02e-05	0.000234	CcSEcCtD
Progesterone—Convulsion—Methotrexate—lung cancer	3e-05	0.000233	CcSEcCtD
Progesterone—Vomiting—Etoposide—lung cancer	3e-05	0.000233	CcSEcCtD
Progesterone—Erythema—Doxorubicin—lung cancer	3e-05	0.000233	CcSEcCtD
Progesterone—Malnutrition—Doxorubicin—lung cancer	3e-05	0.000233	CcSEcCtD
Progesterone—Rash—Etoposide—lung cancer	2.98e-05	0.000231	CcSEcCtD
Progesterone—Dermatitis—Etoposide—lung cancer	2.98e-05	0.000231	CcSEcCtD
Progesterone—Headache—Etoposide—lung cancer	2.96e-05	0.000229	CcSEcCtD
Progesterone—Flatulence—Doxorubicin—lung cancer	2.96e-05	0.000229	CcSEcCtD
Progesterone—Myalgia—Methotrexate—lung cancer	2.95e-05	0.000229	CcSEcCtD
Progesterone—Arthralgia—Methotrexate—lung cancer	2.95e-05	0.000229	CcSEcCtD
Progesterone—Chest pain—Methotrexate—lung cancer	2.95e-05	0.000229	CcSEcCtD
Progesterone—Tension—Doxorubicin—lung cancer	2.95e-05	0.000228	CcSEcCtD
Progesterone—Vomiting—Paclitaxel—lung cancer	2.95e-05	0.000228	CcSEcCtD
Progesterone—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lung cancer	2.93e-05	0.000227	CcSEcCtD
Progesterone—Rash—Paclitaxel—lung cancer	2.92e-05	0.000226	CcSEcCtD
Progesterone—Dermatitis—Paclitaxel—lung cancer	2.92e-05	0.000226	CcSEcCtD
Progesterone—Discomfort—Methotrexate—lung cancer	2.92e-05	0.000226	CcSEcCtD
Progesterone—Nervousness—Doxorubicin—lung cancer	2.92e-05	0.000226	CcSEcCtD
Progesterone—Back pain—Doxorubicin—lung cancer	2.9e-05	0.000225	CcSEcCtD
Progesterone—Headache—Paclitaxel—lung cancer	2.9e-05	0.000225	CcSEcCtD
Progesterone—Hypersensitivity—Docetaxel—lung cancer	2.89e-05	0.000224	CcSEcCtD
Progesterone—Muscle spasms—Doxorubicin—lung cancer	2.89e-05	0.000224	CcSEcCtD
Progesterone—Confusional state—Methotrexate—lung cancer	2.85e-05	0.000221	CcSEcCtD
Progesterone—Anaphylactic shock—Methotrexate—lung cancer	2.83e-05	0.000219	CcSEcCtD
Progesterone—Vision blurred—Doxorubicin—lung cancer	2.83e-05	0.000219	CcSEcCtD
Progesterone—Asthenia—Docetaxel—lung cancer	2.82e-05	0.000218	CcSEcCtD
Progesterone—Infection—Methotrexate—lung cancer	2.81e-05	0.000218	CcSEcCtD
Progesterone—Nausea—Etoposide—lung cancer	2.81e-05	0.000217	CcSEcCtD
Progesterone—Ill-defined disorder—Doxorubicin—lung cancer	2.79e-05	0.000216	CcSEcCtD
Progesterone—Pruritus—Docetaxel—lung cancer	2.78e-05	0.000215	CcSEcCtD
Progesterone—Nervous system disorder—Methotrexate—lung cancer	2.78e-05	0.000215	CcSEcCtD
Progesterone—Anaemia—Doxorubicin—lung cancer	2.78e-05	0.000215	CcSEcCtD
Progesterone—Nausea—Paclitaxel—lung cancer	2.75e-05	0.000213	CcSEcCtD
Progesterone—Skin disorder—Methotrexate—lung cancer	2.75e-05	0.000213	CcSEcCtD
Progesterone—Hyperhidrosis—Methotrexate—lung cancer	2.74e-05	0.000212	CcSEcCtD
Progesterone—Malaise—Doxorubicin—lung cancer	2.71e-05	0.00021	CcSEcCtD
Progesterone—Vertigo—Doxorubicin—lung cancer	2.7e-05	0.000209	CcSEcCtD
Progesterone—Anorexia—Methotrexate—lung cancer	2.7e-05	0.000209	CcSEcCtD
Progesterone—Syncope—Doxorubicin—lung cancer	2.69e-05	0.000209	CcSEcCtD
Progesterone—Diarrhoea—Docetaxel—lung cancer	2.69e-05	0.000208	CcSEcCtD
Progesterone—Palpitations—Doxorubicin—lung cancer	2.65e-05	0.000206	CcSEcCtD
Progesterone—Hypotension—Methotrexate—lung cancer	2.64e-05	0.000205	CcSEcCtD
Progesterone—Loss of consciousness—Doxorubicin—lung cancer	2.64e-05	0.000204	CcSEcCtD
Progesterone—Cough—Doxorubicin—lung cancer	2.62e-05	0.000203	CcSEcCtD
Progesterone—Convulsion—Doxorubicin—lung cancer	2.6e-05	0.000201	CcSEcCtD
Progesterone—Dizziness—Docetaxel—lung cancer	2.6e-05	0.000201	CcSEcCtD
Progesterone—Hypertension—Doxorubicin—lung cancer	2.59e-05	0.000201	CcSEcCtD
Progesterone—Musculoskeletal discomfort—Methotrexate—lung cancer	2.58e-05	0.0002	CcSEcCtD
Progesterone—Insomnia—Methotrexate—lung cancer	2.56e-05	0.000198	CcSEcCtD
Progesterone—Myalgia—Doxorubicin—lung cancer	2.56e-05	0.000198	CcSEcCtD
Progesterone—Chest pain—Doxorubicin—lung cancer	2.56e-05	0.000198	CcSEcCtD
Progesterone—Arthralgia—Doxorubicin—lung cancer	2.56e-05	0.000198	CcSEcCtD
Progesterone—Anxiety—Doxorubicin—lung cancer	2.55e-05	0.000197	CcSEcCtD
Progesterone—Paraesthesia—Methotrexate—lung cancer	2.54e-05	0.000197	CcSEcCtD
Progesterone—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—lung cancer	2.54e-05	0.000197	CcSEcCtD
Progesterone—Discomfort—Doxorubicin—lung cancer	2.53e-05	0.000196	CcSEcCtD
Progesterone—Dyspnoea—Methotrexate—lung cancer	2.52e-05	0.000195	CcSEcCtD
Progesterone—Somnolence—Methotrexate—lung cancer	2.52e-05	0.000195	CcSEcCtD
Progesterone—Dry mouth—Doxorubicin—lung cancer	2.5e-05	0.000194	CcSEcCtD
Progesterone—Vomiting—Docetaxel—lung cancer	2.5e-05	0.000193	CcSEcCtD
Progesterone—Dyspepsia—Methotrexate—lung cancer	2.49e-05	0.000193	CcSEcCtD
Progesterone—Rash—Docetaxel—lung cancer	2.48e-05	0.000192	CcSEcCtD
Progesterone—Dermatitis—Docetaxel—lung cancer	2.47e-05	0.000192	CcSEcCtD
Progesterone—Confusional state—Doxorubicin—lung cancer	2.47e-05	0.000191	CcSEcCtD
Progesterone—Decreased appetite—Methotrexate—lung cancer	2.46e-05	0.000191	CcSEcCtD
Progesterone—Headache—Docetaxel—lung cancer	2.46e-05	0.000191	CcSEcCtD
Progesterone—Anaphylactic shock—Doxorubicin—lung cancer	2.45e-05	0.00019	CcSEcCtD
Progesterone—Oedema—Doxorubicin—lung cancer	2.45e-05	0.00019	CcSEcCtD
Progesterone—Gastrointestinal disorder—Methotrexate—lung cancer	2.44e-05	0.000189	CcSEcCtD
Progesterone—Fatigue—Methotrexate—lung cancer	2.44e-05	0.000189	CcSEcCtD
Progesterone—Infection—Doxorubicin—lung cancer	2.43e-05	0.000189	CcSEcCtD
Progesterone—Pain—Methotrexate—lung cancer	2.42e-05	0.000187	CcSEcCtD
Progesterone—Shock—Doxorubicin—lung cancer	2.41e-05	0.000187	CcSEcCtD
Progesterone—Nervous system disorder—Doxorubicin—lung cancer	2.4e-05	0.000186	CcSEcCtD
Progesterone—Tachycardia—Doxorubicin—lung cancer	2.39e-05	0.000185	CcSEcCtD
Progesterone—Skin disorder—Doxorubicin—lung cancer	2.38e-05	0.000184	CcSEcCtD
Progesterone—Hyperhidrosis—Doxorubicin—lung cancer	2.37e-05	0.000183	CcSEcCtD
Progesterone—Anorexia—Doxorubicin—lung cancer	2.34e-05	0.000181	CcSEcCtD
Progesterone—Nausea—Docetaxel—lung cancer	2.33e-05	0.000181	CcSEcCtD
Progesterone—Feeling abnormal—Methotrexate—lung cancer	2.33e-05	0.000181	CcSEcCtD
Progesterone—Gastrointestinal pain—Methotrexate—lung cancer	2.31e-05	0.000179	CcSEcCtD
Progesterone—Hypotension—Doxorubicin—lung cancer	2.29e-05	0.000177	CcSEcCtD
Progesterone—Urticaria—Methotrexate—lung cancer	2.25e-05	0.000174	CcSEcCtD
Progesterone—Abdominal pain—Methotrexate—lung cancer	2.24e-05	0.000173	CcSEcCtD
Progesterone—Body temperature increased—Methotrexate—lung cancer	2.24e-05	0.000173	CcSEcCtD
Progesterone—Musculoskeletal discomfort—Doxorubicin—lung cancer	2.23e-05	0.000173	CcSEcCtD
Progesterone—Insomnia—Doxorubicin—lung cancer	2.22e-05	0.000172	CcSEcCtD
Progesterone—Paraesthesia—Doxorubicin—lung cancer	2.2e-05	0.00017	CcSEcCtD
Progesterone—Dyspnoea—Doxorubicin—lung cancer	2.18e-05	0.000169	CcSEcCtD
Progesterone—Somnolence—Doxorubicin—lung cancer	2.18e-05	0.000169	CcSEcCtD
Progesterone—Dyspepsia—Doxorubicin—lung cancer	2.16e-05	0.000167	CcSEcCtD
Progesterone—Decreased appetite—Doxorubicin—lung cancer	2.13e-05	0.000165	CcSEcCtD
Progesterone—Gastrointestinal disorder—Doxorubicin—lung cancer	2.12e-05	0.000164	CcSEcCtD
Progesterone—Fatigue—Doxorubicin—lung cancer	2.11e-05	0.000164	CcSEcCtD
Progesterone—Pain—Doxorubicin—lung cancer	2.1e-05	0.000162	CcSEcCtD
Progesterone—Constipation—Doxorubicin—lung cancer	2.1e-05	0.000162	CcSEcCtD
Progesterone—Hypersensitivity—Methotrexate—lung cancer	2.09e-05	0.000161	CcSEcCtD
Progesterone—Asthenia—Methotrexate—lung cancer	2.03e-05	0.000157	CcSEcCtD
Progesterone—Feeling abnormal—Doxorubicin—lung cancer	2.02e-05	0.000156	CcSEcCtD
Progesterone—Gastrointestinal pain—Doxorubicin—lung cancer	2e-05	0.000155	CcSEcCtD
Progesterone—Pruritus—Methotrexate—lung cancer	2e-05	0.000155	CcSEcCtD
Progesterone—Urticaria—Doxorubicin—lung cancer	1.95e-05	0.000151	CcSEcCtD
Progesterone—Body temperature increased—Doxorubicin—lung cancer	1.94e-05	0.00015	CcSEcCtD
Progesterone—Abdominal pain—Doxorubicin—lung cancer	1.94e-05	0.00015	CcSEcCtD
Progesterone—Diarrhoea—Methotrexate—lung cancer	1.94e-05	0.00015	CcSEcCtD
Progesterone—Dizziness—Methotrexate—lung cancer	1.87e-05	0.000145	CcSEcCtD
Progesterone—Hypersensitivity—Doxorubicin—lung cancer	1.81e-05	0.00014	CcSEcCtD
Progesterone—Vomiting—Methotrexate—lung cancer	1.8e-05	0.000139	CcSEcCtD
Progesterone—Rash—Methotrexate—lung cancer	1.78e-05	0.000138	CcSEcCtD
Progesterone—Dermatitis—Methotrexate—lung cancer	1.78e-05	0.000138	CcSEcCtD
Progesterone—Headache—Methotrexate—lung cancer	1.77e-05	0.000137	CcSEcCtD
Progesterone—Asthenia—Doxorubicin—lung cancer	1.76e-05	0.000136	CcSEcCtD
Progesterone—Pruritus—Doxorubicin—lung cancer	1.73e-05	0.000134	CcSEcCtD
Progesterone—Nausea—Methotrexate—lung cancer	1.68e-05	0.00013	CcSEcCtD
Progesterone—Diarrhoea—Doxorubicin—lung cancer	1.68e-05	0.00013	CcSEcCtD
Progesterone—Dizziness—Doxorubicin—lung cancer	1.62e-05	0.000126	CcSEcCtD
Progesterone—Vomiting—Doxorubicin—lung cancer	1.56e-05	0.000121	CcSEcCtD
Progesterone—Rash—Doxorubicin—lung cancer	1.55e-05	0.00012	CcSEcCtD
Progesterone—Dermatitis—Doxorubicin—lung cancer	1.54e-05	0.00012	CcSEcCtD
Progesterone—Headache—Doxorubicin—lung cancer	1.54e-05	0.000119	CcSEcCtD
Progesterone—Nausea—Doxorubicin—lung cancer	1.46e-05	0.000113	CcSEcCtD
Progesterone—CYP2C9—Metabolism—GSTP1—lung cancer	1.81e-06	1.82e-05	CbGpPWpGaD
Progesterone—SLC22A3—Metabolism—PIK3CA—lung cancer	1.8e-06	1.82e-05	CbGpPWpGaD
Progesterone—ABCB1—Metabolism—TYMS—lung cancer	1.8e-06	1.82e-05	CbGpPWpGaD
Progesterone—OPRK1—Signaling by GPCR—AKT1—lung cancer	1.8e-06	1.82e-05	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	1.8e-06	1.81e-05	CbGpPWpGaD
Progesterone—NR3C1—Gene Expression—MAPK3—lung cancer	1.79e-06	1.8e-05	CbGpPWpGaD
Progesterone—ABCC1—Disease—EGFR—lung cancer	1.79e-06	1.8e-05	CbGpPWpGaD
Progesterone—ABCB1—Metabolism—GSTM1—lung cancer	1.78e-06	1.79e-05	CbGpPWpGaD
Progesterone—CYP1B1—Metabolism—PTEN—lung cancer	1.78e-06	1.79e-05	CbGpPWpGaD
Progesterone—CYP2D6—Metabolism—CAT—lung cancer	1.78e-06	1.79e-05	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—HPGDS—lung cancer	1.78e-06	1.79e-05	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—ENO2—lung cancer	1.78e-06	1.79e-05	CbGpPWpGaD
Progesterone—ESR1—Gene Expression—MYC—lung cancer	1.77e-06	1.78e-05	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—PPP2R1B—lung cancer	1.77e-06	1.78e-05	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism—CAT—lung cancer	1.76e-06	1.78e-05	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—EP300—lung cancer	1.76e-06	1.77e-05	CbGpPWpGaD
Progesterone—CYP17A1—Metabolism—AKT1—lung cancer	1.76e-06	1.77e-05	CbGpPWpGaD
Progesterone—ABCC1—Metabolism—EP300—lung cancer	1.76e-06	1.77e-05	CbGpPWpGaD
Progesterone—CYP3A5—Metabolism—PIK3CG—lung cancer	1.75e-06	1.77e-05	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism of lipids and lipoproteins—EP300—lung cancer	1.75e-06	1.76e-05	CbGpPWpGaD
Progesterone—NR3C1—Gene Expression—MYC—lung cancer	1.74e-06	1.76e-05	CbGpPWpGaD
Progesterone—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	1.74e-06	1.75e-05	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism—CYP1A1—lung cancer	1.73e-06	1.74e-05	CbGpPWpGaD
Progesterone—SLC22A1—Metabolism—PIK3CB—lung cancer	1.73e-06	1.74e-05	CbGpPWpGaD
Progesterone—CYP2D6—Metabolism—ABCB1—lung cancer	1.73e-06	1.74e-05	CbGpPWpGaD
Progesterone—ABCB11—Metabolism—PIK3CA—lung cancer	1.73e-06	1.74e-05	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—GSTT1—lung cancer	1.72e-06	1.74e-05	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism—ERCC2—lung cancer	1.72e-06	1.73e-05	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism—ABCB1—lung cancer	1.71e-06	1.73e-05	CbGpPWpGaD
Progesterone—SLC22A1—Metabolism—PTGS2—lung cancer	1.71e-06	1.73e-05	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—SRC—lung cancer	1.71e-06	1.73e-05	CbGpPWpGaD
Progesterone—CYP2A6—Metabolism—PIK3CB—lung cancer	1.7e-06	1.72e-05	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—CYP2A6—lung cancer	1.7e-06	1.72e-05	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—GCLC—lung cancer	1.7e-06	1.72e-05	CbGpPWpGaD
Progesterone—CYP2D6—Metabolism—TYMS—lung cancer	1.7e-06	1.71e-05	CbGpPWpGaD
Progesterone—CYP1B1—Metabolism—EP300—lung cancer	1.7e-06	1.71e-05	CbGpPWpGaD
Progesterone—ABCB1—Metabolism—CYP1A1—lung cancer	1.69e-06	1.7e-05	CbGpPWpGaD
Progesterone—ABCC1—Disease—KRAS—lung cancer	1.69e-06	1.7e-05	CbGpPWpGaD
Progesterone—CYP2A6—Metabolism—PTGS2—lung cancer	1.69e-06	1.7e-05	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism—TYMS—lung cancer	1.68e-06	1.7e-05	CbGpPWpGaD
Progesterone—CYP2D6—Metabolism—GSTM1—lung cancer	1.68e-06	1.69e-05	CbGpPWpGaD
Progesterone—ABCB1—Metabolism—ERCC2—lung cancer	1.67e-06	1.69e-05	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—STK11—lung cancer	1.67e-06	1.68e-05	CbGpPWpGaD
Progesterone—CYP3A5—Metabolism—POMC—lung cancer	1.67e-06	1.68e-05	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—VEGFA—lung cancer	1.67e-06	1.68e-05	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism—GSTM1—lung cancer	1.66e-06	1.68e-05	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—PIK3CA—lung cancer	1.66e-06	1.68e-05	CbGpPWpGaD
Progesterone—CYP2C8—Metabolism—APOA1—lung cancer	1.66e-06	1.68e-05	CbGpPWpGaD
Progesterone—CYP1A1—Metabolism—PIK3CG—lung cancer	1.66e-06	1.67e-05	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—STAT3—lung cancer	1.65e-06	1.66e-05	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—NRAS—lung cancer	1.65e-06	1.66e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—MDM2—lung cancer	1.65e-06	1.66e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—RAF1—lung cancer	1.64e-06	1.65e-05	CbGpPWpGaD
Progesterone—CYP3A5—Metabolism—CREBBP—lung cancer	1.62e-06	1.64e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—ERBB2—lung cancer	1.62e-06	1.64e-05	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—ENO1—lung cancer	1.61e-06	1.63e-05	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—TP53—lung cancer	1.61e-06	1.62e-05	CbGpPWpGaD
Progesterone—CYP3A7—Metabolism—PTEN—lung cancer	1.61e-06	1.62e-05	CbGpPWpGaD
Progesterone—SLC22A2—Metabolism—PTEN—lung cancer	1.6e-06	1.61e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—MTOR—lung cancer	1.6e-06	1.61e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—PIK3CB—lung cancer	1.6e-06	1.61e-05	CbGpPWpGaD
Progesterone—AR—Gene Expression—AKT1—lung cancer	1.59e-06	1.6e-05	CbGpPWpGaD
Progesterone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	1.59e-06	1.6e-05	CbGpPWpGaD
Progesterone—CYP2D6—Metabolism—CYP1A1—lung cancer	1.59e-06	1.6e-05	CbGpPWpGaD
Progesterone—CYP2D6—Metabolism—ERCC2—lung cancer	1.58e-06	1.59e-05	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—MAPK3—lung cancer	1.58e-06	1.59e-05	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism—CYP1A1—lung cancer	1.58e-06	1.59e-05	CbGpPWpGaD
Progesterone—CYP1A1—Metabolism—POMC—lung cancer	1.58e-06	1.59e-05	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—lung cancer	1.57e-06	1.58e-05	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism—ERCC2—lung cancer	1.56e-06	1.58e-05	CbGpPWpGaD
Progesterone—ABCC1—Disease—PIK3CA—lung cancer	1.55e-06	1.56e-05	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—GSTP1—lung cancer	1.55e-06	1.56e-05	CbGpPWpGaD
Progesterone—CYP3A5—Metabolism—PIK3CD—lung cancer	1.54e-06	1.55e-05	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—HRAS—lung cancer	1.54e-06	1.55e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—CXCL8—lung cancer	1.54e-06	1.55e-05	CbGpPWpGaD
Progesterone—CYP1A1—Metabolism—CREBBP—lung cancer	1.54e-06	1.55e-05	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—MYC—lung cancer	1.53e-06	1.55e-05	CbGpPWpGaD
Progesterone—CYP3A7—Metabolism—EP300—lung cancer	1.53e-06	1.54e-05	CbGpPWpGaD
Progesterone—SLC22A2—Metabolism—EP300—lung cancer	1.53e-06	1.54e-05	CbGpPWpGaD
Progesterone—CYP3A5—Metabolism—ALB—lung cancer	1.52e-06	1.53e-05	CbGpPWpGaD
Progesterone—CYP2C8—Metabolism—PIK3CG—lung cancer	1.52e-06	1.53e-05	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—CAT—lung cancer	1.51e-06	1.52e-05	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—EGFR—lung cancer	1.5e-06	1.51e-05	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism of lipids and lipoproteins—EP300—lung cancer	1.5e-06	1.51e-05	CbGpPWpGaD
Progesterone—SLC22A1—Metabolism—PTEN—lung cancer	1.49e-06	1.51e-05	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism—APOA1—lung cancer	1.48e-06	1.5e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—CASP3—lung cancer	1.47e-06	1.48e-05	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—IL6—lung cancer	1.47e-06	1.48e-05	CbGpPWpGaD
Progesterone—SLC22A3—Metabolism—AKT1—lung cancer	1.47e-06	1.48e-05	CbGpPWpGaD
Progesterone—CYP2A6—Metabolism—PTEN—lung cancer	1.47e-06	1.48e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—IL2—lung cancer	1.47e-06	1.48e-05	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—ABCB1—lung cancer	1.46e-06	1.48e-05	CbGpPWpGaD
Progesterone—CYP1A1—Metabolism—PIK3CD—lung cancer	1.46e-06	1.47e-05	CbGpPWpGaD
Progesterone—ABCB1—Metabolism—APOA1—lung cancer	1.45e-06	1.46e-05	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—CYP2E1—lung cancer	1.45e-06	1.46e-05	CbGpPWpGaD
Progesterone—CYP2C8—Metabolism—POMC—lung cancer	1.45e-06	1.46e-05	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—TYMS—lung cancer	1.44e-06	1.45e-05	CbGpPWpGaD
Progesterone—CYP1A1—Metabolism—ALB—lung cancer	1.44e-06	1.45e-05	CbGpPWpGaD
Progesterone—ABCC1—Disease—HRAS—lung cancer	1.43e-06	1.45e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—CCND1—lung cancer	1.43e-06	1.44e-05	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—NQO1—lung cancer	1.43e-06	1.44e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—JUN—lung cancer	1.43e-06	1.44e-05	CbGpPWpGaD
Progesterone—SLC22A1—Metabolism—EP300—lung cancer	1.42e-06	1.44e-05	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—GSTM1—lung cancer	1.42e-06	1.43e-05	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	1.42e-06	1.43e-05	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—KRAS—lung cancer	1.42e-06	1.43e-05	CbGpPWpGaD
Progesterone—ABCB11—Metabolism—AKT1—lung cancer	1.41e-06	1.42e-05	CbGpPWpGaD
Progesterone—CYP2C8—Metabolism—CREBBP—lung cancer	1.41e-06	1.42e-05	CbGpPWpGaD
Progesterone—CYP2A6—Metabolism—EP300—lung cancer	1.4e-06	1.41e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—MMP9—lung cancer	1.39e-06	1.4e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—CDKN1A—lung cancer	1.39e-06	1.4e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—PTEN—lung cancer	1.38e-06	1.39e-05	CbGpPWpGaD
Progesterone—ABCC1—Disease—IL6—lung cancer	1.37e-06	1.38e-05	CbGpPWpGaD
Progesterone—CYP2D6—Metabolism—APOA1—lung cancer	1.37e-06	1.38e-05	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—AKT1—lung cancer	1.36e-06	1.37e-05	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism—PIK3CG—lung cancer	1.35e-06	1.37e-05	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism—APOA1—lung cancer	1.35e-06	1.36e-05	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—CYP1A1—lung cancer	1.35e-06	1.36e-05	CbGpPWpGaD
Progesterone—CYP3A5—Metabolism—PIK3CB—lung cancer	1.34e-06	1.35e-05	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—ERCC2—lung cancer	1.34e-06	1.35e-05	CbGpPWpGaD
Progesterone—CYP2C8—Metabolism—PIK3CD—lung cancer	1.33e-06	1.34e-05	CbGpPWpGaD
Progesterone—CYP3A5—Metabolism—PTGS2—lung cancer	1.33e-06	1.34e-05	CbGpPWpGaD
Progesterone—ABCB1—Metabolism—PIK3CG—lung cancer	1.32e-06	1.33e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—EP300—lung cancer	1.32e-06	1.33e-05	CbGpPWpGaD
Progesterone—CYP2C8—Metabolism—ALB—lung cancer	1.32e-06	1.33e-05	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—PIK3CA—lung cancer	1.3e-06	1.31e-05	CbGpPWpGaD
Progesterone—ABCC1—Metabolism—PIK3CA—lung cancer	1.3e-06	1.31e-05	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	1.3e-06	1.31e-05	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—STK11—lung cancer	1.29e-06	1.3e-05	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism—POMC—lung cancer	1.29e-06	1.3e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—SRC—lung cancer	1.28e-06	1.29e-05	CbGpPWpGaD
Progesterone—CYP1A1—Metabolism—PIK3CB—lung cancer	1.27e-06	1.28e-05	CbGpPWpGaD
Progesterone—ABCC1—Disease—AKT1—lung cancer	1.27e-06	1.28e-05	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—TP53—lung cancer	1.26e-06	1.27e-05	CbGpPWpGaD
Progesterone—ABCB1—Metabolism—POMC—lung cancer	1.26e-06	1.27e-05	CbGpPWpGaD
Progesterone—CYP1A1—Metabolism—PTGS2—lung cancer	1.26e-06	1.27e-05	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism—CREBBP—lung cancer	1.26e-06	1.27e-05	CbGpPWpGaD
Progesterone—CYP1B1—Metabolism—PIK3CA—lung cancer	1.26e-06	1.27e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—VEGFA—lung cancer	1.25e-06	1.26e-05	CbGpPWpGaD
Progesterone—CYP2D6—Metabolism—PIK3CG—lung cancer	1.25e-06	1.26e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—STAT3—lung cancer	1.24e-06	1.25e-05	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism—PIK3CG—lung cancer	1.24e-06	1.24e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—NRAS—lung cancer	1.23e-06	1.24e-05	CbGpPWpGaD
Progesterone—ESR1—Gene Expression—AKT1—lung cancer	1.23e-06	1.24e-05	CbGpPWpGaD
Progesterone—ABCB1—Metabolism—CREBBP—lung cancer	1.23e-06	1.24e-05	CbGpPWpGaD
Progesterone—NR3C1—Gene Expression—AKT1—lung cancer	1.21e-06	1.22e-05	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—HRAS—lung cancer	1.21e-06	1.21e-05	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—GSTP1—lung cancer	1.19e-06	1.2e-05	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism—PIK3CD—lung cancer	1.19e-06	1.2e-05	CbGpPWpGaD
Progesterone—CYP2D6—Metabolism—POMC—lung cancer	1.19e-06	1.2e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—MAPK3—lung cancer	1.18e-06	1.19e-05	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism—POMC—lung cancer	1.18e-06	1.18e-05	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism—ALB—lung cancer	1.18e-06	1.18e-05	CbGpPWpGaD
Progesterone—CYP2C8—Metabolism—PIK3CB—lung cancer	1.16e-06	1.17e-05	CbGpPWpGaD
Progesterone—ABCB1—Metabolism—PIK3CD—lung cancer	1.16e-06	1.17e-05	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—CAT—lung cancer	1.16e-06	1.17e-05	CbGpPWpGaD
Progesterone—CYP3A5—Metabolism—PTEN—lung cancer	1.16e-06	1.17e-05	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—APOA1—lung cancer	1.16e-06	1.17e-05	CbGpPWpGaD
Progesterone—CYP2D6—Metabolism—CREBBP—lung cancer	1.16e-06	1.16e-05	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—IL6—lung cancer	1.15e-06	1.16e-05	CbGpPWpGaD
Progesterone—CYP2C8—Metabolism—PTGS2—lung cancer	1.15e-06	1.16e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—MYC—lung cancer	1.15e-06	1.16e-05	CbGpPWpGaD
Progesterone—ABCB1—Metabolism—ALB—lung cancer	1.15e-06	1.16e-05	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism—CREBBP—lung cancer	1.15e-06	1.15e-05	CbGpPWpGaD
Progesterone—CYP3A7—Metabolism—PIK3CA—lung cancer	1.13e-06	1.14e-05	CbGpPWpGaD
Progesterone—SLC22A2—Metabolism—PIK3CA—lung cancer	1.13e-06	1.14e-05	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—ABCB1—lung cancer	1.13e-06	1.14e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—EGFR—lung cancer	1.12e-06	1.13e-05	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—TYMS—lung cancer	1.11e-06	1.12e-05	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	1.11e-06	1.12e-05	CbGpPWpGaD
Progesterone—CYP3A5—Metabolism—EP300—lung cancer	1.11e-06	1.11e-05	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—GSTM1—lung cancer	1.1e-06	1.11e-05	CbGpPWpGaD
Progesterone—CYP1A1—Metabolism—PTEN—lung cancer	1.1e-06	1.1e-05	CbGpPWpGaD
Progesterone—CYP2D6—Metabolism—PIK3CD—lung cancer	1.1e-06	1.1e-05	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism—PIK3CD—lung cancer	1.09e-06	1.09e-05	CbGpPWpGaD
Progesterone—CYP2D6—Metabolism—ALB—lung cancer	1.08e-06	1.09e-05	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism—ALB—lung cancer	1.07e-06	1.08e-05	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—AKT1—lung cancer	1.06e-06	1.07e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—KRAS—lung cancer	1.06e-06	1.07e-05	CbGpPWpGaD
Progesterone—ABCC1—Metabolism—AKT1—lung cancer	1.06e-06	1.07e-05	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—PIK3CG—lung cancer	1.06e-06	1.06e-05	CbGpPWpGaD
Progesterone—SLC22A1—Metabolism—PIK3CA—lung cancer	1.05e-06	1.06e-05	CbGpPWpGaD
Progesterone—CYP1A1—Metabolism—EP300—lung cancer	1.05e-06	1.05e-05	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—CYP1A1—lung cancer	1.04e-06	1.05e-05	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism—PIK3CB—lung cancer	1.04e-06	1.05e-05	CbGpPWpGaD
Progesterone—CYP2A6—Metabolism—PIK3CA—lung cancer	1.04e-06	1.05e-05	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—ERCC2—lung cancer	1.03e-06	1.04e-05	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism—PTGS2—lung cancer	1.03e-06	1.04e-05	CbGpPWpGaD
Progesterone—CYP1B1—Metabolism—AKT1—lung cancer	1.03e-06	1.03e-05	CbGpPWpGaD
Progesterone—ABCB1—Metabolism—PIK3CB—lung cancer	1.01e-06	1.02e-05	CbGpPWpGaD
Progesterone—CYP2C8—Metabolism—PTEN—lung cancer	1.01e-06	1.01e-05	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—POMC—lung cancer	1e-06	1.01e-05	CbGpPWpGaD
Progesterone—ABCB1—Metabolism—PTGS2—lung cancer	1e-06	1.01e-05	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—CREBBP—lung cancer	9.79e-07	9.86e-06	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—PIK3CA—lung cancer	9.76e-07	9.84e-06	CbGpPWpGaD
Progesterone—CYP2C8—Metabolism—EP300—lung cancer	9.59e-07	9.66e-06	CbGpPWpGaD
Progesterone—CYP2D6—Metabolism—PIK3CB—lung cancer	9.55e-07	9.62e-06	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism—PIK3CB—lung cancer	9.47e-07	9.54e-06	CbGpPWpGaD
Progesterone—CYP2D6—Metabolism—PTGS2—lung cancer	9.46e-07	9.53e-06	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—TP53—lung cancer	9.44e-07	9.52e-06	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism—PTGS2—lung cancer	9.38e-07	9.45e-06	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—PIK3CD—lung cancer	9.28e-07	9.35e-06	CbGpPWpGaD
Progesterone—CYP3A7—Metabolism—AKT1—lung cancer	9.25e-07	9.32e-06	CbGpPWpGaD
Progesterone—SLC22A2—Metabolism—AKT1—lung cancer	9.24e-07	9.31e-06	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—ALB—lung cancer	9.16e-07	9.23e-06	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—HRAS—lung cancer	9.03e-07	9.1e-06	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism—PTEN—lung cancer	8.97e-07	9.04e-06	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—APOA1—lung cancer	8.93e-07	8.99e-06	CbGpPWpGaD
Progesterone—ABCB1—Metabolism—PTEN—lung cancer	8.76e-07	8.82e-06	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—IL6—lung cancer	8.65e-07	8.71e-06	CbGpPWpGaD
Progesterone—SLC22A1—Metabolism—AKT1—lung cancer	8.61e-07	8.67e-06	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism—EP300—lung cancer	8.56e-07	8.62e-06	CbGpPWpGaD
Progesterone—CYP2A6—Metabolism—AKT1—lung cancer	8.48e-07	8.54e-06	CbGpPWpGaD
Progesterone—ABCB1—Metabolism—EP300—lung cancer	8.35e-07	8.41e-06	CbGpPWpGaD
Progesterone—CYP2D6—Metabolism—PTEN—lung cancer	8.25e-07	8.31e-06	CbGpPWpGaD
Progesterone—CYP3A5—Metabolism—PIK3CA—lung cancer	8.19e-07	8.25e-06	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism—PTEN—lung cancer	8.18e-07	8.24e-06	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—PIK3CG—lung cancer	8.15e-07	8.21e-06	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—PIK3CB—lung cancer	8.09e-07	8.15e-06	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—PTGS2—lung cancer	8.02e-07	8.08e-06	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—AKT1—lung cancer	7.98e-07	8.04e-06	CbGpPWpGaD
Progesterone—CYP2D6—Metabolism—EP300—lung cancer	7.87e-07	7.93e-06	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism—EP300—lung cancer	7.8e-07	7.86e-06	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—POMC—lung cancer	7.76e-07	7.81e-06	CbGpPWpGaD
Progesterone—CYP1A1—Metabolism—PIK3CA—lung cancer	7.73e-07	7.79e-06	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—CREBBP—lung cancer	7.55e-07	7.61e-06	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—PIK3CD—lung cancer	7.16e-07	7.22e-06	CbGpPWpGaD
Progesterone—CYP2C8—Metabolism—PIK3CA—lung cancer	7.09e-07	7.14e-06	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—ALB—lung cancer	7.07e-07	7.12e-06	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—PTEN—lung cancer	6.99e-07	7.04e-06	CbGpPWpGaD
Progesterone—CYP3A5—Metabolism—AKT1—lung cancer	6.69e-07	6.74e-06	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—EP300—lung cancer	6.67e-07	6.72e-06	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism—PIK3CA—lung cancer	6.33e-07	6.38e-06	CbGpPWpGaD
Progesterone—CYP1A1—Metabolism—AKT1—lung cancer	6.32e-07	6.37e-06	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—PIK3CB—lung cancer	6.24e-07	6.29e-06	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—PTGS2—lung cancer	6.19e-07	6.23e-06	CbGpPWpGaD
Progesterone—ABCB1—Metabolism—PIK3CA—lung cancer	6.18e-07	6.22e-06	CbGpPWpGaD
Progesterone—CYP2D6—Metabolism—PIK3CA—lung cancer	5.82e-07	5.86e-06	CbGpPWpGaD
Progesterone—CYP2C8—Metabolism—AKT1—lung cancer	5.79e-07	5.84e-06	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism—PIK3CA—lung cancer	5.77e-07	5.81e-06	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—PTEN—lung cancer	5.4e-07	5.44e-06	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism—AKT1—lung cancer	5.17e-07	5.21e-06	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—EP300—lung cancer	5.15e-07	5.18e-06	CbGpPWpGaD
Progesterone—ABCB1—Metabolism—AKT1—lung cancer	5.05e-07	5.08e-06	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—PIK3CA—lung cancer	4.93e-07	4.97e-06	CbGpPWpGaD
Progesterone—CYP2D6—Metabolism—AKT1—lung cancer	4.76e-07	4.79e-06	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism—AKT1—lung cancer	4.71e-07	4.75e-06	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—AKT1—lung cancer	4.03e-07	4.06e-06	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—PIK3CA—lung cancer	3.81e-07	3.83e-06	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—AKT1—lung cancer	3.11e-07	3.13e-06	CbGpPWpGaD
